Oppo R17 Pro to launch in India today: Specs, expected price and how to watch livestream

Oppo is all set to bring its premium R-series to India for the very first time today. The company is holding an event in Mumbai where it will announce the Oppo R17 Pro, a device that brings a premium design language complete with an edge-to-edge waterdrop display, all-glass body and an in-display fingerprint sensor, among other things. The R17 Pro is the first top-end smartphone launch for Oppo in India since the Find X. The Oppo R17 Pro also touts superior mid-range performance, championed by a Snapdragon 710 chipset, as well as SuperVOOC fast charging support.

The Oppo R17 Pro was first launched in China before it made its way to Europe a few weeks ago. The phone was launched at CNY 4,299 (approx Rs 43,800) in China, but you can expect the India pricing to be more competitive as the R17 Pro will compete against the OnePlus 6T, Samsung Galaxy A9 and the upcoming Nokia 8.1. So, a pricing of around Rs 30,000 would give the R17 Pro a good chance against the competition. Oppo may also launch the regular R17 today, but the spotlight will be on the Pro model. The Oppo R17 Pro is already up for pre-orders, but the company will be officially launching the product later today at 8pm IST. Oppo will be livestreaming the event via its YouTube channel.

The Oppo R17 Pro brings a 6.4-inch FHD+ waterdrop display with a 91.5 percent screen-to-body ratio. It also gets Gorilla Glass protection on the back along with a gradient colour scheme. It is powered by a powerful mid-range octa-core Snapdragon 710 chipset coupled with up to 8GB of RAM and 128GB of internal storage. The R17 Pro also comes with an in-display fingerprint sensor.

The R17 Pro touts a triple camera system on the back. This includes a one 12MP sensor with variable aperture (f/1.5-2.4) and OIS, a 20MP secondary sensor with f/1.6 aperture and a third Time of Flight (TOF) 3D sensing camera that calculates depth information for 3D-like photos. The upcoming Oppo smartphone houses a 3,700mAH battery with a 40W SuperVOOC fast charging support which promises to charge the device from zero to 40 per cent in just 10 minutes.

[“source=indiatoday]

Trump Says Drug Companies to Unveil Price Cuts in Two Weeks

Image result for Trump Says Drug Companies to Unveil Price Cuts in Two Weeks

Major pharmaceutical companies will announce “voluntary, massive” cuts in drug prices in two weeks, President Donald Trump said Wednesday, without providing details.

“We’re also working very hard at getting the cost of medicine down, and I think people are going to start to see for the first time ever in this country a major drop in the cost of prescription drugs,” Trump said while signing legislation making it easier for terminally ill patients to get access to experimental drugs.

The president said drug company executives, whom he didn’t name, would visit the White House to make the announcement. The White House didn’t respond to a request for further details.

Pharmaceutical companies contacted about Trump’s remarks on price cuts said they were unaware of any such plans.

The Nasdaq Biotechnology Index pared gains after Trump’s comments before recovering. The index closed up 1.4 percent in New York.

Trump announced a plan earlier this month to bring down drug prices in the U.S., though doubts that the proposals would amount to much led pharmaceutical stocks to climb at the time. The president has a habit of promising actions in two weeks and then missing those deadlines.

Read more: In Trump’s White House, everything’s coming in ‘two weeks’

Trump on Wednesday also touted new rules his administration is poised to release that would expand loosely regulated short-term insurance plans and let small firms band together under association health plans to act more like larger employers and buy cheaper health coverage.

“We’re going to have great, inexpensive, really good health care,” Trump said.

Many groups, including insurance companies and patient advocates, have raised concerns that the new rules would raise the cost of coverage for sick patients who need Obamacare coverage and can’t switch to cheaper plans that will offer fewer benefits.

[“Source-bloomberg”]